Get the deepest insights and evidence-based advice to map your compound’s winning pricing, value and access journey – for markets across the world

Our Services

Akceso, as an independent advisor, maintains a worldwide network of pharma Payers and Clinician KOLs to inform our thinking and advice –
in nearly any country, across therapy areas and any stage of a product’s lifecycle

Pricing Strategy

Develop the plan that brings optimal P&R results to your company and access to patients in need.

Payer Research

Gain deep consumer insights with the help of our primary and secondary research.

Pricing & Reimbursement Value Dossier

Bring you strategy to successful implementation.

Managed Entry Agreements

Take the right steps to create win-win-win outcomes for payers, patients and company.

Pricing Launch Plan & Sequencing

Maximize global revenue with the right launch price & sequence plan – applying Akceso’s ‘Real Options Approach’.

Pricing & Reimbursement Negotiation Road Map

Establish a framework for consistently successful negotiations.

Loss of Exclusivity Optimization

Preserve and capture value through a well planned transition to generic competition – both from an originator and a newcomer perspective.

Pricing Due Diligence

Assess the pricing & reimbursement potential of your compound in licensing-in and licensing-out situations.

Are you interested?

SMEs and Big pharma firms have obtained material benefits relying on our advice. Contact us to explore together how you could.

"Global top pharma firms have access to a wide range of service providers. Akceso offers unique capabilities in the area of pricing that we were able to use to our benefit."
Head Government & Public Affairs Europe, major Swiss pharma company
"Akceso’s output can be directly inserted into our regional and local pricing & access plan."
Senior Manager Value & Access EU, global biopharma
Scroll to Top